How lungs trigger innate lymphoid cell dyn...The cells surrounding structures play an important role as cues from the immune system in guiding their motility and behaviour, researchers from the UK and the US report. more ➔
Researchers find clue to Parkinson’s... An enzyme that clears out alpha-synuclein from neurons may counteract Parkinsons Disease, report researchers from ETH Zürich and Novartis. more ➔
Chikungunya vaccine developer Themis bags...Under a partnering ageement with CEPI, Themis Bioscience will receive $21m to push pivotal testing of MV-CHIK, its Chikungunya vaccine candidate. more ➔
Genetically modified fungus stops malaria... A fungus that produces an insecticide can stop the spread of Anopheles mosquito, which causes malaria. more ➔
Abacus Medicine postpones IPO European pharmaceutical parallel trade company Abacus Medicine A/S has postponed its planned Initial Public Offering (IPO), due to "unfavourable market environment". more ➔
Make leukaemia therapy saferA Belgian-British-Australian research team has created a safer version of a therapy that combats the aggressive form of a blood cancer called acute lymphoblastic leukemia (ALL) while avoiding toxici … more ➔
Nanobiotix spins out CuradigmCancer-focussed Nanobiotix SA has spun out Curadigm, which offers a platform to improve the bioavailability of nanomedicines by reducing liver and spleen toxicity and accumulation. more ➔
Double win for NovartisIt was a good day for Novartis: A second drug with huge selling potential has been approved for the US market. The FDA gave the go ahead for breast cancer drug Piqray (alpelisib), the first and only … more ➔
Most expensive gene therapy globally appro... The FDA has approved Novartis-subsidiary AveXis Inc’s spinal muscular atrophy (SMA) gene therapy Zolgensma (onasemnogene abeparvovec-xioi). The company wants to set the price tag at $2,125m per dos … more ➔
Healthy figures from SpainAt BioEquity 2019, Spanish Bioindustry Association ASEBIO has given a sneak peek into its 2018 Annual Report, that each year describes the news and trends from the Spanish Biotech Sector. more ➔
